Literature DB >> 32376103

Critical Concerns About 2019 Novel Coronavirus Infection in Pediatric Population.

Chunya Wang1, Pan Zhao2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32376103      PMCID: PMC7164845          DOI: 10.1016/j.mayocp.2020.04.008

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


× No keyword cloud information.
During the past few weeks, the spread of 2019 novel coronavirus (2019-nCov) has gathered international momentum, yet today, its epidemiology remains poorly understood. For example, there is no certainty about the source of the outbreak, and the natural reservoir host of the virus has not yet been identified. Such uncertainties challenge the control of the epidemic. At the time of writing, the number of reported cases infected with 2019-nCov globally continues to increase. However, according to the existing data, the reported number of pediatric cases with confirmed 2019-nCov infection is not high, and the majority of pediatric patients appear to have mild or asymptomatic cases.2, 3, 4 Nonetheless, there are several concerns that particularly apply to the pediatric population. How can children be protected against infection within the family? Because no vaccines against the 2019-nCov are currently available, isolation from the source of infection becomes the most important prophylactic measure. It is noted that the absolute majority of reported pediatric cases with confirmed 2019-nCov infection have familial clusters. , Therefore, it is crucial to raise self-protection awareness for every family member, including older children. For infants and younger children, adult family members should take sufficient preventive measures. These are especially important for families with children who live in crowded conditions in big cities. Can a child infected by 2019-nCov be expeditiously and accurately diagnosed? Because the presentation of 2019-nCov infection in children is nonspecific and the false negativity of throat swab sample test exists, the diagnosis is often difficult. Also, asymptomatic infection may not be rare in children. A recent retrospective study involving 34 confirmed pediatric 2019-nCovinfected cases, aged between 10 months and 18 years, showed that 9 cases (26%) had no clinical symptoms, 6 of whom were found to have pulmonary abnormalities in computed tomographic images. In view of such issues, the diagnostic criteria of pediatric infection with 2019-nCov should be more accurately specified, with the aim of distinguishing the affected cases effectively and ensuring a timely diagnosis. In the meanwhile, proper and strict measures should be put in practice to avoid cross-infections in the daily management of febrile pediatric cases in clinics and observation wards, given that the early symptoms of children infected with 2019-nCov resemble those arising from other respiratory tract infections. Is the clinical prognosis of the pediatric cases with confirmed 2019-nCov infection generally better than that of adult cases? Based on the limited data currently available from pediatric cases, mortality to date has scarcely been reported. Taken together and based on available evidence, it seems that the clinical prognosis of pediatric affected cases may be less severe as compared with adults with the disease. However, due to the lack of effective therapeutic approaches, vigilance must be exercised about viral variation and any corresponding changes in the transmissibility and pathogenicity. Considering the scarcity of studies of pediatric patients, the answer to this question remains unresolved. Should the psychological health of the children who are isolated due to the infection or separated from their infected family members be evaluated? For these children, isolation restrictions are severe, leading to separation from their parents or other family members for a period of time. Experience during the severe acute respiratory syndrome (SARS) outbreaks showed that the negative impact of isolation on children separated from their families remained a psychosocial concern in pediatric settings. We accordingly suggest that pediatric health care providers or guardians of entrustment pay attention to the emotional status of these children and ways that may safeguard their emotional health. Collectively, as stated by some recent studies, limited travel and less exposure may be responsible for the current low number of affected pediatric cases. , However, concerns have been expressed regarding the possibility of a large increase in pediatric cases in the school and kindergarten setting. Accordingly, risk evaluation of the 2019-nCov infection in children merit continued emphasis, and understanding of the 2019-nCov infection in the pediatric population must be vigorously and continually sought.
  5 in total

1.  Bowlby and Robertson revisited: the impact of isolation on hospitalized children during SARS.

Authors:  Donna F Koller; David B Nicholas; Robyn Salter Goldie; Robin Gearing; Enid K Selkirk
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

2.  Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China.

Authors:  Minggui Lin; Lai Wei; Lixin Xie; Guangfa Zhu; Charles S Dela Cruz; Lokesh Sharma
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China.

Authors:  Min Wei; Jingping Yuan; Yu Liu; Tao Fu; Xue Yu; Zhi-Jiang Zhang
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

4.  [Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen].

Authors:  X F Wang; J Yuan; Y J Zheng; J Chen; Y M Bao; Y R Wang; L F Wang; H Li; J X Zeng; Y H Zhang; Y X Liu; L Liu
Journal:  Zhonghua Er Ke Za Zhi       Date:  2020-02-17

5.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.